Topical Lidocaine (5% patch)
Treatment for Peripheral Neuropathy
Effectiveness
60%
Safety Score
85%
Clinical Trials
7
Participants
9K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
85
DangerousModerateSafe
Treatment Details
0
Topical Lidocaine (5% patch) Outcomes
for Peripheral Neuropathy
Efficacy Outcomes
Overall Effectiveness
+60%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
4 completed trials for Topical Lidocaine (5% patch) in Peripheral Neuropathy
Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy
NCT01086150COMPLETEDPHASE2, PHASE3
51 participants
INTERVENTIONAL
Albany, United States
Started: Oct 1, 2009
Symptom Management After Breast Cancer Surgery
NCT00686127COMPLETEDPHASE4
21 participants
INTERVENTIONAL
San Francisco, United States
Started: Sep 1, 2003
Topical Lidocaine: Predictors of Response in Peripheral Nerve Injury
NCT01112748COMPLETEDPHASE4
24 participants
INTERVENTIONAL
Aarhus C, Denmark
Started: Apr 1, 2010
A Mechanistic Evaluation of the Nociceptive Desensitizing Properties of Topical Capsaicin
NCT03587220COMPLETEDNA
44 participants
INTERVENTIONAL
Aalborg, Denmark
Started: Aug 1, 2018